Rebase Inc
TSE:5138
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rebase Inc
TSE:5138
|
JP |
|
L
|
Link Pharma Chem Limited
BSE:524748
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Rebase Inc's stock price target?
Not Available
Rebase Inc doesn't have any price targets made by Wall Street professionals.
What is Rebase Inc's Revenue forecast?
Projected CAGR
11%
For the last 3 years the compound annual growth rate for Rebase Inc's revenue is 29%. The projected CAGR for the next 3 years is 11%.
What is Rebase Inc's Net Income forecast?
Projected CAGR
-39%
For the last 3 years the compound annual growth rate for Rebase Inc's net income is 37%. The projected CAGR for the next 3 years is -39%.